Shares of Becton Dickinson & Co. BDX slipped 1.11% to $224.92 Tuesday, on what proved to be an all-around grim trading ...

The stock's rise snapped a four-day losing streak.

Proficio Capital Partners LLC bought a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during ...

Medical-device maker Becton Dickinson and Co. accused a former area sales director of bolting to a competitor in violation of ...

Becton, Dickinson and Company (NYSE:BDX – Get Free Report)’s stock price fell 0.3% during trading on Thursday following insider selling activity. The company traded as low as $222.01 and last traded ...

Nearly a third of medical device adverse events were not submitted to the FDA within a 30-day regulatory window, with most ...

Learn more about whether Becton, Dickinson and Company or GE HealthCare Technologies Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics ...

A new study found that 9.1% of medical device AEs were reported to the FDA 180 days later than required over a three-year ...

On Tuesday, 11 March 2025, Becton Dickinson (NYSE: BDX) presented at the Barclays 27th Annual Global Healthcare Conference, outlining its strategic focus on separating its Life Sciences business ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Citi analyst Joanne Wuensch reiterated a Buy rating on Becton Dickinson (BDX – Research Report) today. The company’s shares closed yesterday at ...

My monthly update and commentary on the top dividend stock picks sourced from Barron's, March 2025 edition. Standout choices ...